T1	Participants 81 121	patients with early rheumatoid arthritis
T2	Participants 196 287	patients with early rheumatoid arthritis (RA) undergoing longterm treatment with etanercept
T3	Participants 297 523	Patients with early RA (disease duration of 3 years or less) who had completed a 2-year efficacy study comparing etanercept and methotrexate (MTX) were followed in an extension where they received 25 mg etanercept twice weekly
T4	Participants 999 1053	patients who completed 5 years of etanercept treatment
T5	Participants 1348 1373	in patients with early RA
T6	Participants 1615 1651	in patients with early aggressive RA
